|
Class 2 Device Recall CELLTRACKS ANALYZER II |
|
Date Initiated by Firm |
December 28, 2012 |
Date Posted |
August 10, 2013 |
Recall Status1 |
Terminated 3 on August 11, 2015 |
Recall Number |
Z-1950-2013 |
Recall Event ID |
64304 |
510(K)Number |
K122821 K110406
|
Product Classification |
System, immunomagnetic, circulating cancer cell, enumeration - Product Code NQI
|
Product |
CELLTRACKS ANALYZER II (Software Version 2.5.1 & Below.
Product Usage: The CELLTRACKS AUTOPREP System is a general purpose laboratory instrument used with immunomagnetic reagents that capture and enrich target cells, and labeling reagents that differentiate cells in whole blood. Cell analyzers such as the CellTracks Analyzer II, CellSpotter System, flow cytometers or microscopes may be used for cell identification and enumeration. The system is fit for in vitro diagnostic use. In the CellTracks Analyzer II software 2.5.1 release notes Pub. No. J40136EN issued 2012-03-26 page 1, the document states that the edit patient sample information screen now includes a patient information section, a new feature unique to software 2.5.1. This section provides a drop down for patient race and cancer type. There are also separate fields for first and last name for both the physician and patient. There is no mention of the drop down patient ID box on the right side of the user interface which auto-populates previous sample data.
|
Code Information |
CELLTRACKS ANALYZER II (Software Version 2.5.1 & Below). Product Code: CT1476B (9555). |
Recalling Firm/ Manufacturer |
Veridex, LLC 1001 US Route 202 Raritan NJ 08869-0606
|
For Additional Information Contact |
Joseph Falvo 585-218-1300
|
Manufacturer Reason for Recall |
Veridex, LLC has received a report that a patient's demographics were incorrectly associated with another patient's identification (PID) number. The purpose of this notification is to inform you of the issue and provide instructions to help prevent an occurrence on your CELLTRACKS AUTOPREP System and CELLTRACKS ANALYZER II.
|
FDA Determined Cause 2 |
Software design |
Action |
Veridex sent an Important Product Correction Notification letter dated December 28, 2012, to all affected customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to complete and return the Confirmation of Receipt form. For questions contact Customer Technical Services at 1-800-421-3311. |
Quantity in Commerce |
US: 70 Units; Ex-US 76 Units |
Distribution |
Worldwide Distribution - USA Nationwide and the countries of Australia, Canada, China, India, Japan, Singapore, England, France, Germany, Italy and Spain. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = NQI and Original Applicant = VERIDEX, LLC
|
|
|
|